Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate in early stage COVID-19
NCT05054322Phase 3Unknown
- Sponsor
- University of Medicine and Pharmacy of Ho Chi Minh City
- Start
- Sep 2021
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in coronavirus disease 2019 (COVID-19), sponsored by University of Medicine and Pharmacy of Ho Chi Minh City. Status: unknown.
02
Drugs
fluticasone propionate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05054322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05054322.